Core Viewpoint - The China Securities Hong Kong 100 Pharmaceutical and Health Index has shown significant growth, with a year-to-date increase of 89.44% and a recent one-month increase of 20.84% [1]. Group 1: Index Performance - The China Securities Hong Kong 100 Pharmaceutical and Health Index reported a value of 1095.17 points [1]. - The index has increased by 44.95% over the past three months [1]. - The index is based on a sample of securities classified according to the China Securities industry classification standards, with a base date of December 31, 2004, set at 1000.0 points [1]. Group 2: Index Composition - The index is fully composed of securities listed on the Hong Kong Stock Exchange, with a 100.00% allocation [1]. - The composition by industry includes: - Chemical drugs: 55.11% - Biological drugs: 18.62% - Pharmaceutical and biotechnology services: 14.56% - Medical commerce and services: 11.71% [1]. Group 3: Index Adjustment Mechanism - The index samples are adjusted biannually, specifically on the next trading day following the second Friday of June and December [2]. - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]. - Adjustments occur in response to changes in the parent index, special events affecting industry classification, or the delisting of sample companies [2].
中证香港100医药卫生指数报1095.17点，前十大权重包含石药集团等